142 related articles for article (PubMed ID: 25113253)
1. Vascular marker expression during the development of various types of gynaecological malignancy.
Urban P; Rabajdova MB; Varga J; Kruzliak P; Fialkovicova V; Durovcova E; Marekova M
Tumour Biol; 2014 Nov; 35(11):11229-35. PubMed ID: 25113253
[TBL] [Abstract][Full Text] [Related]
2. Breast carcinoma progression and tumour vascular markers related to apoptotic mechanisms.
Bilecova-Rabajdova M; Urban P; Gregova K; Varga J; Fialkovicová V; Kruzliak P; Marekova M
Dis Markers; 2014; 2014():156034. PubMed ID: 24696529
[TBL] [Abstract][Full Text] [Related]
3. Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
Obermayr E; Sanchez-Cabo F; Tea MK; Singer CF; Krainer M; Fischer MB; Sehouli J; Reinthaller A; Horvat R; Heinze G; Tong D; Zeillinger R
BMC Cancer; 2010 Dec; 10():666. PubMed ID: 21129172
[TBL] [Abstract][Full Text] [Related]
4. GPM6B Inhibit PCa Proliferation by Blocking Prostate Cancer Cell Serotonin Absorptive Capacity.
He S; Huang Z; Li X; Ding Y; Sheng H; Liu B; Jia Z
Dis Markers; 2020; 2020():8810756. PubMed ID: 33294057
[TBL] [Abstract][Full Text] [Related]
5. Identification of GPM6A and GPM6B as potential new human lymphoid leukemia-associated oncogenes.
Charfi C; Edouard E; Rassart E
Cell Oncol (Dordr); 2014 Jun; 37(3):179-91. PubMed ID: 24916915
[TBL] [Abstract][Full Text] [Related]
6. Real-time RT-PCR systems for CTC detection from blood samples of breast cancer and gynaecological tumour patients (Review).
Andergassen U; Kölbl AC; Mahner S; Jeschke U
Oncol Rep; 2016 Apr; 35(4):1905-15. PubMed ID: 26848098
[TBL] [Abstract][Full Text] [Related]
7. Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies.
Zafrakas M; Petschke B; Donner A; Fritzsche F; Kristiansen G; Knüchel R; Dahl E
BMC Cancer; 2006 Apr; 6():88. PubMed ID: 16603086
[TBL] [Abstract][Full Text] [Related]
8. Expression of mRNA for osteoprotegerin and receptor activator of nuclear factor kappa beta ligand (RANKL) during root resorption induced by the application of heavy orthodontic forces on rat molars.
Low E; Zoellner H; Kharbanda OP; Darendeliler MA
Am J Orthod Dentofacial Orthop; 2005 Oct; 128(4):497-503. PubMed ID: 16214633
[TBL] [Abstract][Full Text] [Related]
9. Roles of fibroblast growth factor-inducible 14 in hepatocellular carcinoma.
Li N; Hu WJ; Shi J; Xue J; Guo WX; Zhang Y; Guan DX; Liu SP; Cheng YQ; Wu MC; Xie D; Liu SR; Cheng SQ
Asian Pac J Cancer Prev; 2013; 14(6):3509-14. PubMed ID: 23886137
[TBL] [Abstract][Full Text] [Related]
10. Expression of estrogen receptor exon 5 splicing variant (ER E5SV) mRNA in gynaecological cancers.
Fujimoto J; Ichigo S; Hirose R; Hori M; Tamaya T
J Steroid Biochem Mol Biol; 1997 Jan; 60(1-2):25-30. PubMed ID: 9182855
[TBL] [Abstract][Full Text] [Related]
11. SUSD2 is frequently downregulated and functions as a tumor suppressor in RCC and lung cancer.
Cheng Y; Wang X; Wang P; Li T; Hu F; Liu Q; Yang F; Wang J; Xu T; Han W
Tumour Biol; 2016 Jul; 37(7):9919-30. PubMed ID: 26815503
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of
Ecke TH; Kiani A; Schlomm T; Friedersdorff F; Rabien A; Jung K; Kilic E; Boström P; Tervahartiala M; Taimen P; Gleichenhagen J; Johnen G; Brüning T; Koch S; Roggisch J; Wirtz RM
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050010
[TBL] [Abstract][Full Text] [Related]
13. Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation.
Chen G; Sircar K; Aprikian A; Potti A; Goltzman D; Rabbani SA
Cancer; 2006 Jul; 107(2):289-98. PubMed ID: 16752412
[TBL] [Abstract][Full Text] [Related]
14. Synaptic vesicle protein 2 (SV2) isoforms.
Bandala C; Miliar-García A; Mejía-Barradas CM; Anaya-Ruiz M; Luna-Arias JP; Bazán-Méndez CI; Gómez-López M; Juárez-Méndez S; Lara-Padilla E
Asian Pac J Cancer Prev; 2012; 13(10):5063-7. PubMed ID: 23244111
[TBL] [Abstract][Full Text] [Related]
15. Detection of tumor cell-specific mRNA in the peripheral blood of patients with breast cancer—evaluation of several markers with real-time reverse transcription-PCR.
Andergassen U; Hofmann S; Kölbl AC; Schindlbeck C; Neugebauer J; Hutter S; Engelstädter V; Ilmer M; Friese K; Jeschke U
Int J Mol Sci; 2013 Jan; 14(1):1093-104. PubMed ID: 23299436
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin levels in patients with papillary thyroid cancer according to the presence of Hashimoto's thyroiditis.
Park SH; Park CS; Kim YI; Nam-Goong IS; Kim YS; Lee JC; Choi JI; Park JW; Kim ES
Asian Pac J Cancer Prev; 2015; 16(6):2447-51. PubMed ID: 25824779
[TBL] [Abstract][Full Text] [Related]
17. Alterations in expression pattern of splicing factors in epithelial ovarian cancer and its clinical impact.
Iborra S; Hirschfeld M; Jaeger M; Zur Hausen A; Braicu I; Sehouli J; Gitsch G; Stickeler E
Int J Gynecol Cancer; 2013 Jul; 23(6):990-6. PubMed ID: 23748175
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of Dicer expression in cervical cancer tissues.
Zhao H; Jin X; Su H; Deng X; Fang Y; Shen L; Xie C
Med Oncol; 2014 May; 31(5):937. PubMed ID: 24676997
[TBL] [Abstract][Full Text] [Related]
19. SKP2/P27Kip1 pathway is associated with Advanced Ovarian Cancer in Saudi Patients.
Hafez MM; Alhoshani AR; Al-Hosaini KA; Alsharari SD; Al Rejaie SS; Sayed-Ahmed MM; Al-Shabanah OA
Asian Pac J Cancer Prev; 2015; 16(14):5807-15. PubMed ID: 26320455
[TBL] [Abstract][Full Text] [Related]
20. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
